
Integer Holdings Corporation ITGR
$ 85.37
-0.29%
Annual report 2025
added 02-23-2026
Integer Holdings Corporation Accounts Payables 2011-2026 | ITGR
Accounts payable — are the obligations of an organization to other legal entities or individuals that arise in cases when the company has acquired goods or services on deferred payment terms, has not paid taxes and fees, has wage arrears to employees, or has received loans and other liabilities. Accounts payable arise when an organization has already received some benefit but has not yet paid for it.Main types of accounts payable
| Type of liability | Example |
|---|---|
| To suppliers and contractors | Goods received but not yet paid for |
| Taxes and fees | VAT, income tax, etc., not paid on time |
| Salaries | Employee wages not paid |
| To budgets | Insurance contributions to funds not paid |
| To founders | Founders provided borrowed funds |
| To banks | Overdue loan payments |
| Other | Fines, penalties, forfeits, customer prepayments, etc. |
Impact on the company's financial performance
- Liquidity and solvency
Accounts payable are part of short-term liabilities, so they affect liquidity ratios - Financial stability
The higher the share of borrowed funds (including accounts payable), the lower the company's level of independence - Capital turnover
Moderate accounts payable can positively affect working capital by allowing the company to use “free” financing from suppliers (payment deferrals) - Risks and reputation
Large and especially overdue accounts payable may indicate financial difficulties. This can deter investors, partners, and lenders, and at a critical level of debt and lack of resources to repay it, bankruptcy proceedings may be initiated
Annual Accounts Payables Integer Holdings Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 113 M | 101 M | 118 M | 111 M | 76.9 M | 51.6 M | 65 M | 57.2 M | 83.5 M | 77.9 M | 46.4 M | 46.5 M | - | 45.3 M | 40.7 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 118 M | 40.7 M | 73.9 M |
Quarterly Accounts Payables Integer Holdings Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111 M | 117 M | 112 M | 101 M | 117 M | 119 M | 116 M | 118 M | 108 M | 108 M | 124 M | 111 M | 101 M | - | 90 M | 76.9 M | 68.4 M | 69.3 M | 62.4 M | 51.6 M | 51.6 M | 51.6 M | 51.6 M | 65 M | 65 M | 65 M | 65 M | 57.2 M | 57.2 M | 57.2 M | 57.2 M | 64.6 M | 64.6 M | 64.6 M | 83.5 M | 77.9 M | 77.9 M | 77.9 M | 77.9 M | 46.4 M | 56.3 M | 44.9 M | 43.1 M | 46.5 M | 45 M | 43.9 M | 43.1 M | - | 36.5 M | 42.7 M | 43.2 M | 45.3 M | 45.3 M | 45.3 M | 45.3 M | 40.7 M | 40.7 M | 40.7 M | 40.7 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 124 M | 36.5 M | 69.3 M |
Accounts Payables of other stocks in the Medical devices industry
| Issuer | Accounts Payables | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acutus Medical
AFIB
|
2.76 M | - | -26.83 % | $ 2.62 M | ||
|
AdaptHealth Corp.
AHCO
|
352 M | $ 12.0 | -0.58 % | $ 1.62 B | ||
|
Allied Healthcare Products
AHPI
|
1.21 M | - | 3.58 % | $ 2.21 M | ||
|
ClearPoint Neuro
CLPT
|
1.26 M | $ 9.15 | -2.51 % | $ 259 M | ||
|
Bruker Corporation
BRKR
|
234 M | $ 36.35 | -1.05 % | $ 5.42 K | ||
|
Apollo Endosurgery
APEN
|
7.42 M | - | - | $ 475 M | ||
|
OrthoPediatrics Corp.
KIDS
|
18.8 M | $ 15.71 | -1.44 % | $ 369 M | ||
|
EDAP TMS S.A.
EDAP
|
5.71 M | $ 3.4 | -1.73 % | $ 127 M | ||
|
Avinger
AVGR
|
777 K | - | -20.74 % | $ 369 K | ||
|
Align Technology
ALGN
|
109 M | $ 168.12 | -2.18 % | $ 12.6 B | ||
|
AxoGen
AXGN
|
2.89 M | $ 31.05 | -4.87 % | $ 1.43 B | ||
|
Axonics Modulation Technologies
AXNX
|
9.07 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
4.79 M | - | 1.37 % | $ 20.5 M | ||
|
Butterfly Network
BFLY
|
4.25 M | $ 4.01 | -2.91 % | $ 849 M | ||
|
Cytosorbents Corporation
CTSO
|
2.87 M | $ 0.61 | 3.37 % | $ 38 M | ||
|
TELA Bio
TELA
|
2.31 M | $ 0.69 | 9.81 % | $ 32.4 M | ||
|
BIOLASE
BIOL
|
6.06 M | - | -13.19 % | $ 166 K | ||
|
Delcath Systems
DCTH
|
2.66 M | $ 9.65 | -0.52 % | $ 346 M | ||
|
FONAR Corporation
FONR
|
1.55 M | $ 18.58 | -0.11 % | $ 122 M | ||
|
Boston Scientific Corporation
BSX
|
1.14 B | $ 61.35 | -1.93 % | $ 90.8 B | ||
|
Alphatec Holdings
ATEC
|
40.9 M | $ 11.1 | 1.19 % | $ 1.67 B | ||
|
CONMED Corporation
CNMD
|
93.6 M | $ 34.34 | 0.81 % | $ 1.07 B | ||
|
Globus Medical
GMED
|
98.9 M | $ 90.53 | 2.15 % | $ 12.2 B | ||
|
Edwards Lifesciences Corporation
EW
|
228 M | $ 80.81 | -0.42 % | $ 47.3 B | ||
|
Helius Medical Technologies
HSDT
|
531 K | $ 1.76 | -7.37 % | $ 1.07 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
82.5 M | $ 9.31 | - | $ 717 M | ||
|
Inspire Medical Systems
INSP
|
36.6 M | $ 54.8 | 1.25 % | $ 1.61 B | ||
|
IRIDEX Corporation
IRIX
|
5.38 M | $ 1.0 | 0.34 % | $ 16.9 M | ||
|
Conformis
CFMS
|
4.16 M | - | - | $ 16.4 M | ||
|
LENSAR
LNSR
|
19 M | $ 5.84 | -0.85 % | $ 69.8 M | ||
|
Cardiovascular Systems
CSII
|
14.4 M | - | 0.15 % | $ 844 M | ||
|
Cutera
CUTR
|
19.8 M | - | -10.19 % | $ 1.99 M | ||
|
Medtronic PLC
MDT
|
2.45 B | $ 86.48 | 0.22 % | $ 111 B | ||
|
Dynatronics Corporation
DYNT
|
3.4 M | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
6.5 M | - | - | $ 10.2 M | ||
|
Myomo
MYO
|
1.51 M | $ 0.67 | -4.29 % | $ 28 M | ||
|
Second Sight Medical Products
EYES
|
1.03 M | - | -0.97 % | $ 54.4 M |